CN Patent

CN1320886C — 安非他酮与抗惊厥药在制备治疗肥胖症的药物的用途

Assigned to Duke University · Expires 2007-06-13 · 19y expired

What this patent protects

一般而言，本发明涉及肥胖症，具体而言，本发明涉及单独使用例如唑尼沙胺或促进减重的其它抗惊厥药或者联合安非他酮或通过摄取抑制或其它机制增强去甲肾上腺素和/或多巴胺活性的其它化合物来治疗肥胖症和将与其相关的代谢风险因素降至最低的方法。

USPTO Abstract

一般而言，本发明涉及肥胖症，具体而言，本发明涉及单独使用例如唑尼沙胺或促进减重的其它抗惊厥药或者联合安非他酮或通过摄取抑制或其它机制增强去甲肾上腺素和/或多巴胺活性的其它化合物来治疗肥胖症和将与其相关的代谢风险因素降至最低的方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN1320886C
Jurisdiction: CN
Classification: —
Expires: 2007-06-13
Drug substance claim: No
Drug product claim: No
Assignee: Duke University
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.